Your browser doesn't support javascript.
loading
Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
Venditto, Vincent J; Wieczorek, Lindsay; Molnar, Sebastian; Teque, Fernando; Landucci, Gary; Watson, Douglas S; Forthal, Donald; Polonis, Victoria R; Levy, Jay A; Szoka, Francis C.
Afiliação
  • Venditto VJ; Departments of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, San Francisco, California, USA.
  • Wieczorek L; Laboratory of Vaccine Immunology, Walter Reed Army Institute of Research, Military HIV Research Program, Silver Spring, Maryland, USA The Henry M. Jackson Foundation, Bethesda, Maryland, USA.
  • Molnar S; Laboratory of Vaccine Immunology, Walter Reed Army Institute of Research, Military HIV Research Program, Silver Spring, Maryland, USA The Henry M. Jackson Foundation, Bethesda, Maryland, USA.
  • Teque F; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Landucci G; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, Irvine, California, USA.
  • Watson DS; Departments of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, San Francisco, California, USA.
  • Forthal D; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, Irvine, California, USA.
  • Polonis VR; Laboratory of Vaccine Immunology, Walter Reed Army Institute of Research, Military HIV Research Program, Silver Spring, Maryland, USA.
  • Levy JA; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Szoka FC; Departments of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, San Francisco, California, USA szoka@cgl.ucsf.edu.
Clin Vaccine Immunol ; 21(8): 1086-93, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24872518
ABSTRACT
Broadly neutralizing monoclonal antibodies (bNAbs) 2F5 and 4E10 bind to the membrane proximal external region (MPER) of gp41 and also cross-react with phospholipids. In this study, we investigated if chemical modifications on the MPER adjacent to 2F5 and 4E10 epitopes using mimetics of inflammation-associated posttranslational modifications to induce 2F5- and 4E10-like bNAbs can break tolerance. We synthesized a series of chemically modified peptides spanning the MPER. The serine, threonine, and tyrosine residues in the peptides were modified with sulfate, phosphate, or nitrate moieties and presented in liposomes for rabbit immunizations. All immunizations resulted in high antisera titers directed toward both the modified and unmodified immunogens. Tyrosine modification was observed to significantly suppress antiepitope responses. Sera with strong anti-gp140 titers were purified by affinity chromatography toward the MPER peptide and found to possess a higher affinity toward the MPER than did the bNAbs 2F5 and 4E10. Modest neutralization was observed in the H9 neutralization assay, but neutralization was not observed in the TZM-bl cell or peripheral blood mononuclear cell (PBMC) neutralization assay platforms. Although neutralizing antibodies were not induced by this approach, we conclude that chemical modifications can increase the immune responses to poorly immunogenic antigens, suggesting that chemical modification in an appropriate immunization protocol should be explored further as an HIV-1 vaccine strategy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína gp41 do Envelope de HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína gp41 do Envelope de HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article